Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 12 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Coronary Sinus Reducer For The Management Of Symptomatic Heart Failure

    Rochester, MN

  2. AMBER-HFpEF: Assessment Of CK-4021586 In A Multi-Center, Blinded Evaluation Of Safety And Tolerability Results In HFpEF

    Rochester, MN

  3. Inspiratory Muscle Training In HFpEF

    Rochester, MN

  4. Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction

    Rochester, MN

  5. A Study Of Oral Levosimendan In Pulmonary Hypertension With Heart Failure With Preserved Left Ventricular Ejection Fraction

    Rochester, MN

  6. A Study To Evaluate Endovascular Ablation Of The Right Greater Splanchnic Nerve In Subjects Having Heart Failure With Preserved Ejection Fraction

    Rochester, MN

  7. LEVEL-2: LEVosimendan To Improve Exercise Limitation In Patients With PH-HFpEF-2

    Rochester, MN

  8. Myocardial Mechanisms in HFpEF

    Rochester, MN

  9. Ex-CMR In HFpEF

    Rochester, MN

  10. A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD

    Rochester, MN

.

Mayo Clinic Footer